Archive of Cardiovascular Disease

Cost-Effectiveness of Access to Nonemergency Medical Transportation

January, 2006

Adding relatively small transportation costs to an otherwise disease-specific, cost-effective environment does not make improved access to care non-cost-effective. For example, a congestive heart failure monitoring program that is already evaluated as highly cost-effective will not transition to cost-ineffective because of the addition of only incremental transportation costs.

Author

Richard Wallace, Paul Hughes-Cromwick, and Hillary Mull

Cost-Effectiveness of Access to Nonemergency Medical Transportation

January, 2006

Authors find that the provision of NEMT to those who currently lack it results in a net cost savings across the transportation and health care domains for four of these conditions (prenatal care, asthma, heart disease, and diabetes) and is cost-effective for the remaining eight conditions (influenza vaccinations, breast cancer screening, colorectal cancer screening, dental […]

Author

Richard Wallace, Paul Hughes-Cromwick, and Hillary Mull